Evidence map›Paper›PMID 36782249›Full record

ArticleDiagnostic pathology2023

Recurrent central nervous system Rosai-Dorfman disease with KRAS mutation: a case report.

Qingyang Wang, Hongxiang Ren, Liyuan Zheng, Juan Wang, Dingrong Zhong

Open access · goldAbstract readCase Reports
In one paragraph

Article in Diagnostic pathology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Qingyang WangGraduate School of Peking Union Medical College, Beijing, 100006, China.
Hongxiang RenDepartment of Neurosurgery, China-Japan Friendship Hospital, Beijing, 100029, China.
Liyuan ZhengDepartment of Pathology, China-Japan Friendship Hospital, Beijing, 100029, China.
Juan WangGraduate School of Peking Union Medical College, Beijing, 100006, China.
Dingrong ZhongGraduate School of Peking Union Medical College, Beijing, 100006, China. 748803069@qq.com.
China-Japan Friendship Hospital · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRosai-Dorfman disease (RDD) is a rare, non-Langerhans cell histiocytosis of unknown etiology. we report a very rare case of recurrent central nervous system RDD with KRAS gene mutation and review the literature to improve our understanding of this disease. CASE PRESENTATION: A 19-year-old male patient was admitted to our hospital for headache. Cranial magnetic resonance imaging revealed a mass of abnormal signal shadows in the prepontine cistern. The mass was surgically removed and the patient was consequently diagnosed with intracranial Rosai-Dorfman disease. Seven months later, pathological examination confirmed that the RDD had recurred. Next-generation sequencing found KRAS mutation in exon 4 (C.351A > C. P. K117n).

conclusionRDD of the CNS has no distinct clinical manifestations and imaging characteristics, and the final diagnosis should be based on the results of the pathological examination. Although RDD is not currently classified as a neoplastic disorder, some evidence of clonality has changed our understanding of it. Follow up examinations over a long period are necessary to determine the efficacy of treatment.

Indexed as

Histiocytosis, SinusCentral Nervous SystemDiagnosis, DifferentialHumansMaleMutationProto-Oncogene Proteins p21(ras)Young AdultKRAS protein, humanProto-Oncogene Proteins p21(ras)Central nervous systemKRAS mutationRosai-Dorfman diseaseSinus histiocytosis with massive lymphadenopathy

Identifiers

PMID36782249
PMCPMC9926849
OpenAlexW4320489536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.